Abstract:First described in the late 1800's, Sturge-Weber syndrome is one of the more common neurocutaneous disorders. In most cases, it is caused by a somatic mosaic variant in the GNAQ gene driving aberrant overgrowth in endothelial cells which leads to capillary-venous malformations. Characteristic findings are unilateral port-wine stain, ipsilateral parieto-occipital leptomeningeal angioma with calcifications and atrophy, and ipsilateral glaucoma, though there is significant variability. The predilection for facial skin and brain is likely due to common embryologic progenitors. The risk of brain involvement is increased with a hemifacial, forehead, or medial facial port-wine stain. Neurologic features include epilepsy, stroke-like episodes, transient or permanent hemiparesis and visual field deficit, headaches, cognitive and behavioral impairment. Magnetic resonance imaging reveals contrast-enhancing leptomeningeal angiomatosis, progressive atrophy, calcifications, and ipsilateral dilated choroid plexus. The treatment of glaucoma typically requires surgery and port-wine stains are treated with laser therapy. Retrospective data from small cohorts show potential benefits of presymptomatic treatment with anti-seizure medications and/or low dose aspirin. Epilepsy surgery can benefit those with a greater degree of hemiparesis and intractable seizures. Low-dose aspirin has proven effective in lowering the frequency and severity of recoverable stroke-like events. Sirolimus has been reported preliminarily to have satisfactory results regarding cognitive function in pediatric patients but is not a mainstay of treatment to date. Quality of life is often negatively affected by port-wine stain appearance, intractable seizures, headaches, and mood disorders. Future studies are warranted assessing medication and surgery outcomes, quality of life measures, and timing of imaging and treatment initiation.

Severe Sturge-Weber Syndrome in a 9-Year-old Boy: a Great Challenge.

Unmasking Sturge-Weber syndrome in adulthood: a case with extrafacial port-wine stain and delayed neurological symptoms

Research Advances in Diagnosis and Treatment of Sturge-Weber Syndrome

Reconstruction of the Large Face and Scalp Defects of a Patient with Sturge–Weber Syndrome

Preimplantation Genetic Testing (PGT) and Prenatal Diagnosis of Schaaf-Yang Syndrome: A Report of Three Families and a Research on Genotype–Phenotype Correlations

Sturge–Weber syndrome: an update for the pediatrician

Sturge-Weber syndrome in patients with intractable epilepsy:a clinicopathologic study of 7 cases

Current situation and influencing factors of disease uncertainty in parents of children with Sturge‒Weber syndrome: a retrospective study

Diagnostic pathway and management of first seizures in infants with Sturge–Weber syndrome

Resolution of exudative retinal detachment and optic disc edema in a child with Sturge Weber syndrome and congenital cyanotic heart disease after cardiac surgery

Atypical Sturge–Weber Syndrome Requires Confirmation

Clinico-pathological Investigations of One Case of Sturge-Weber Syndrome with Focal Cortical Dysplasia ⅡA

Clinical and pathologic features of Sturge-Weber syndrome in patients with refractory epilepsy

Sturge-Weber Syndrome Is Associated with Cortical Dysplasia ILAE Type IIIc and Excessive Hypertrophic Pyramidal Neurons in Brain Resections for Intractable Epilepsy.

Surgical Treatment for Epilepsy Due to Sturge-Weber Syndrome:A Case Report and Review of the Literature

Sturge-Weber syndrome: an overview of history, genetics, clinical manifestations, and management.

Cerebral Blood Flow and Glucose Metabolism in an Infant with Sturge-Weber Syndrome.

Hemispheric surgery and outcomes of Sturge-Weber syndrome patients under 1 year old

[Research Progress of Sturge-Weber Syndrome Induced Glaucoma].

A novel termination site in a case of Stüve–Wiedemann syndrome: case report and review of literature

Surgical Orthodontic Treatment for Skeletal Maxillary Protrusion in Sturge-Weber Syndrome: A Case Report and Review of the Literature